3. Chest PainChest Pain
5 Million emergency department visits
2 million hospitalizations annually with cost of
more than $8 billion
Cardiac etiology found <1/3rd
2% of patients with acute MI are unrecognized
and discharged from the ED
8. ContCont’’d.. approachd.. approach
2- Site of pain: retrosternal, plural,
epigastric)
3- Radiation:
Neck
Back (interscapular)
Neck, jaw, shoulder, Lt arm
4- Onset:
Sudden
Gradual
MI,MI,
AnginaAngina
ADAD
E. spasmE. spasm
MI, PE, Pneumothorax, ADMI, PE, Pneumothorax, AD
MSK, GI,MSK, GI,
pneumonia, HZpneumonia, HZ
9. ContCont’’d.. approachd.. approach
5- Duration:
< 15 min ( 2- 10) min Stable Angina
Upto 30 min MI, UA
Upto 60 min E.spasm
Few hours PE, pnumothorax
Hours to days pericarditis
Longer HZ
NOTE: <2/3 min less likely to be cardiac.
10. ContCont’’d.. approachd.. approach
6- Aggravating:
Exertion, cold, stress, meals ischemia
Swallowing, postprandial, smoking GI
Deep breathing, movement MSK,
pericarditis
Deep breathing PE, Pneumothorax
NOTE: HZ is not aggravated by anything
13. Physical examinationPhysical examination
A- Vital signs:
- Hypotension can occur in MI,
pericardial temponade, PE, GI bleeding.
- Fever suggests an infectious disease.
B- Inspection and palpation:
- may reveal the rash of shingles,
crepitus associated with rib fracture,
localized pain, signs of trauma.
Hyperesthesia, particularly when
associated with a rash, is often due to
herpes zoster.
14. PHYSICAL EXAM….CONTPHYSICAL EXAM….CONT
C- Cardiopulmonary examination:
In MI may have audible S4, signs of LVF
such as S3,
pericarditis may cause friction rub and
pulsus paradoxus,
BECK’S TRIAD ( JVP, muffled heart
sounds, low BP) suggests cardiac
temponade.
BP variation in both limbs (AD)
Determine if the breath sounds are
symmetric and if there’s wheezes, crackles
etc
15. DIAGNOSTIC EVALUATION:DIAGNOSTIC EVALUATION:
ECG
Cardiac markers: Troponins are the 1st
enzymes to rise and remain elevated for 5 to 14
days.
Echocardiogram: pericardial effusion, valvular
heart disease.
Chest X-ray: Pneumothorax, pnuomonia
Spiral CT, if PE is suspected.
16. DIAGNOSTIC EVALUATIONDIAGNOSTIC EVALUATION
ANA, BUN, Creatinine, TSH, Tuberculosis
skin test , for pericarditis.
Esophageal pH monitoring, if GERD is
suspected.
Patients with musculoskeletal chest pain
might not require any diagnostic testing.
17. LIFE THREATENING CAUSESLIFE THREATENING CAUSES
P is Pericarditis.
A is Acute myocardial infarction.
P is Pneumothorax
P is Pulmonary embolism
A is Aneurysm ( AD)
19. Pulmonary EmbolismPulmonary Embolism
History:
Sudden-onset, sharp
Exacerbated by inspiratory effort
Associated with hemoptysis, sycope, dyspnea, calf
swelling/pain from DVT
Risk factors: immobilization, fracture of a limb, post-
operative complications, hypercoagulable states
(underlying carcinoma, high-dose exogenous estrogen
administration, pregnancy, inherited deficiencies of
antithrombin III, activated protein C, S, lupus
anticoagulant, prior history of DVT/PE [Virchow’s
triad].
20. Investigations:
↓PaO2 and PaCO2 from increase in overall↓
minute ventilation
D-dimer is sensitive but has a low specificity. Do
NOT order it to rule-in a PE!
CXR:
a. Frequently normal.
b. Often non-specific (atelectasis, pleural
effusion).
c. May see Hampton’s hump (area of
infarction),
ECG: sinus tachycardia most common, S1Q3T3
with large embolus (classic, but rare!), look for
right-axis deviation.
Consider Doppler U/S of legs
Spiral CT / VQ
21. Pulmonary EmbolismPulmonary Embolism
Management:
Anticoagulation to prevent further thrombosis
(heparin initially and then warfarine with
therapeutic INR level of 2-3 for 6 months –
length of therapy still controversial).
Thrombolysis if hemodynamically unstable.
Supportive treatment with oxygen, and fluids.
22. Aortic dissection: PresentationAortic dissection: Presentation
Sharp, “tearing” anterior or posterior
chest and back pain.
Typically sudden onset and severe
Chest pain more common with type A
dissections
Complicated by CVA, syncope, MI (RCA)
or HF
23. Aortic dissection: DiagnosisAortic dissection: Diagnosis
Generally suspected by history/physical
Variations in pulses or blood pressure
(>20 mmHG difference between R and L
arm)
ECG: variable depending on
complications
Imaging when stable
◦ CXR: mediastinal widening
◦ CT chest, TEE, MRI other options and all
superior to TTE
28. Aortic Dissection: ManagementAortic Dissection: Management
Type A: Surgical
Type B and uncomplicated: Medical
Type B and complicated (major branch
involved, continued expansion or aortic
rupture
Long term management includes B
blocker, serial imaging at 3, 6 and 12
months and reoperation if indicated
29. Acute ManagementAcute Management
ICU admission
Pain control: Morphine
Reduction of SBP to 100-120 or lowest
tolerated, HR <60, intubate if unstable
◦ IV B blocker 1st
line (labetolol, propranolol, esmolol)
◦ If HR <60 and SBP >100 with good mentation and
renal function nitroprusside
◦ If hypotensive, look for blood loss, tamponade or HF
prior to giving volume
30. PericarditisPericarditis
Chest pain (anterior chest, sharp,
pleuritic, exacerbated by inspiration, can
decrease with leaning forward, radiation
to trapezius)
Often first sign of other systemic disease
Multiple possible etiologies, viral and
autoimmune most common in US
Consider TB outside US
34. Pericarditis: TreatmentPericarditis: Treatment
NSAIDs are mainstay of therapy (IBU or
high dose ASA
Can also use colchicine or
glucocorticoids
Tamponade: conservative management
with monitoring, serial echo, volume
expansion and treatment of underlying
cause vs. pericardiocentesis
37. ACS: General principlesACS: General principles
Unstable Angina
◦ Rest angina: Usually >20 minutes duration
◦ New onset severe angina
◦ Increasing angina( Worsening)-Crescendo
Angina
◦ Angina not relieved by GTN
◦ Post MI Angina
NSTEMI
STEMI
38. Symptoms of ACSSymptoms of ACS
Prolonged CHEST PAIN
ANXIETY
FEAR OF IMPENDING DEATH
BREATHLESSNESS
VOMITING
COLLAPSE
SYNCOPE
SILENT
39. SIGNS OF ACSSIGNS OF ACS
SIGNS OF SYMPATHETIC
ACTIVATION
PALLOR
SWEATING
TACHYCARDIA
SIGNS OF VAGAL STIMULATION
VOMITING
BRADYCARDIA
40. SIGNS of ACSSIGNS of ACS
Signs of impaired myocardial function:
Hypotension, Oliguria, Cold peripheries
Narrow pulse pressure
Raised JVP
S3
Quit S1
Diffuse apical impulse
Basal creps
41. ACSACS
INVESTIGATIONSINVESTIGATIONS
ECG HELPFUL
DIFFICULT INTERPRETATION IN PREVIOUS MI
PATIENTS AND OLD BBB
RARELY NORMAL ECG
IN 1/3 OF MI CASES INITIAL CHANGES MAY NOT
BE DIAGNOSTIC
EARLIEST CHANGE ST ELEVATION
LATER R WAVE SIZE DIMINUTION
Q WAVES IN TRANSMURAL MI
T WAVE INVERSIOn
CHEK AREA OF INFARCTION
42. Unstable Angina NSTEMI STEMI
Non occlusive
thrombus
Non specific
ECG
Normal cardiac
enzymes
Occluding thrombus
sufficient to cause
tissue damage &
mild
myocardial necrosis
ST depression+/-
T wave inversion on
ECG
Elevated cardiac
enzymes
Complete thrombus
occlusion
ST elevations on
ECG or new LBBB
Elevated cardiac
enzymes
More severe
symptoms
46. New LBBBNew LBBB
QRS > 0.12 sec
L Axis deviation
Prominent R wave V1-V3
Prominent S wave 1, aVL, V5-V6
with t-wave inversion
47. Wall AffectedWall Affected Leads Showing STLeads Showing ST
Segment ElevationSegment Elevation
Leads ShowingLeads Showing
Reciprocal STReciprocal ST
Segment DepressionSegment Depression
Suspected CulpritSuspected Culprit
ArteryArtery
SeptalSeptal V1, V2V1, V2 NoneNone Left AnteriorLeft Anterior
Descending (LAD)Descending (LAD)
AnteriorAnterior V3, V4V3, V4 NoneNone Left AnteriorLeft Anterior
Descending (LAD)Descending (LAD)
AnteroseptalAnteroseptal V1, V2, V3, V4V1, V2, V3, V4 NoneNone Left AnteriorLeft Anterior
Descending (LAD)Descending (LAD)
AnterolateralAnterolateral V3, V4, V5, V6,I,V3, V4, V5, V6,I,
aVLaVL
II, III, aVFII, III, aVF Left AnteriorLeft Anterior
Descending (LAD),Descending (LAD),
Circumflex (LCX),Circumflex (LCX),
oror Obtuse MarginalObtuse Marginal
Extensive AnteriorExtensive Anterior
(Sometimes called(Sometimes called
Anteroseptal withAnteroseptal with
Lateral extension)Lateral extension)
V1, V2, V3, V4,V5,V1, V2, V3, V4,V5,
V6, I, aVLV6, I, aVL
II, III, aVFII, III, aVF Left main coronaryLeft main coronary
artery (LCA)artery (LCA)
48. Wall AffectedWall Affected Leads Showing STLeads Showing ST
Segment ElevationSegment Elevation
Leads ShowingLeads Showing
Reciprocal STReciprocal ST
Segment DepressionSegment Depression
Suspected CulpritSuspected Culprit
ArteryArtery
InferiorInferior II, III, aVFII, III, aVF I, aVLI, aVL Right CoronaryRight Coronary
Artery (RCA) orArtery (RCA) or
Circumflex (LCX)Circumflex (LCX)
LateralLateral I, aVL, V5, V6I, aVL, V5, V6 II, III, aVFII, III, aVF Circumflex (LCX),Circumflex (LCX),
oror Obtuse MarginalObtuse Marginal
PosteriorPosterior (Usually(Usually
associated withassociated with
Inferior or LateralInferior or Lateral
but can be isolated)but can be isolated)
V7, V8, V9V7, V8, V9 V1, V2, V3, V4V1, V2, V3, V4 PosteriorPosterior
Descending (PDA)Descending (PDA)
(branch of the(branch of the
RCARCA oror
Circumflex (LCXCircumflex (LCX))
Right ventricularRight ventricular
(Usually associated(Usually associated
with Inferior)with Inferior)
II, III, aVF, V1,II, III, aVF, V1,
V4RV4R
I, aVLI, aVL Right CoronaryRight Coronary
Artery (RCA)Artery (RCA)
49.
50. Myocardial Ischemia or Infarction(ACS)Myocardial Ischemia or Infarction(ACS)
Management: (MONALISA)
Morphine for pain(5-10 mg) if no morphine Pethidine
(75- 100mg) + anti emetic providing systolic BP is
more than 90
Oxygen if hypoxic
Nitro spray/drip for pain
Aspirin
Lasix if in congestive heart failure
Inotropes if in cardigenic shock
Streptokinase (thrompolytics)
Anticoagulation (non Q wave MI : Heparin or LMWH,
Q wave MI :Thrompolytic and Heparin/LMWH)
51.
52. Presentation within 12 hours of chest pain with :
Pain - needle time : 45 min
1)ST elevation >2mm in 2 or more chest leads or
2)ST elevation >1mm in 2 or more limb leads or
3)Posterior infarction ( dominant R wave and ST depression
in V1-V3 leads)
4)New onset of left bundle branch block.
53. Mx of NSTEMIMx of NSTEMI
High-risk patients with non-ST elevation
acute coronary syndrome should be
treated with an intravenous glycoprotein
IIb/IIIa receptor antagonist, particularly if
they are undergoing percutaneous
coronary intervention.
54. Mx of NSTEMI/UAMx of NSTEMI/UA
A Cochrane review of seven randomised
controlled trials (RCTs) (n=11,092)
reported that LMWH (principally
enoxaparin) reduced MI and coronary
revascularisation procedure rates
compared to unfractionated heparin.
There was no difference in mortality or
major bleeding episodes.
55. Mx of STEMIMx of STEMI
Meta-analysis confirms that, in patients
treated with thrombolytic therapy
LMWH(enoxaparin) is associated with
better outcomes
but no decrease in mortality when
compared with unfractionated heparin
56. Prinzemtal’s angina( variant angina or angina
inversa,)
a syndrome typically consisting of angina at rest that
occurs in cycles.
Cause by vasospasm
Features
Symptoms typically occur at rest, rather than on
exertion (attacks usually occur at night).
57. Diagnosis of Prinzmetal Angina
CK MB or troponin l or T may show a degree of
positivity, as coronary spasm too can cause
myocardial damage.
The gold standard is coronary angiography.
ECG finding will more often show ST segment
elevation than ST depression.
60. ACS Risk ScoringACS Risk Scoring
TIMI
◦ Age - Use of aspirin
◦ Risk Factors - Known CAD
◦ > 1 episode rest pain - ST segment deviation
◦ Cardiac risk markers
PURSUIT
◦ Age, Sex - CCS class in last 6/52
◦ Signs of CCF - ST depression on ECG
GRACE
◦ Age - Heart rate and systolic BP
◦ Creatinine - CCF (Killip class)
◦ Cardiac arrest at admission
◦ Elevated cardiac markers - ST segment deviation
63. MUSCULOSKELETAL CHEST PAINMUSCULOSKELETAL CHEST PAIN
ARTHRITIS
COSTOCONDRITI
S
INTERCOSTAL
MUSCLE INJURY
COXSACKIE VIRAL
INFECTION
MINOR SOFT
TISSUE INJURIES
VARY WITHVARY WITH
POSTUREPOSTURE
VARY WITHVARY WITH
POSITIONPOSITION
LOCALLOCAL
TENDERNESSTENDERNESS
64. TEITZE`S SYNDROMETEITZE`S SYNDROME
IDIOPATHIC COSTOCONDRITISIDIOPATHIC COSTOCONDRITIS
LOCALIZED PAIN/TENDERNESS AT
COSTOCONDRAL JUNCTION
ENHANCED BY
EMOTION,COUGHING,SNEEZING
2nd.RIB MOST AFFECTED
65. OESOPHAGEAL PAINOESOPHAGEAL PAIN
CAN MIMIC ANGINAL PAIN
MAY GET PRECIPITATED BY EXERCISE
MAY BE RELIEVED BY NITRATES
RELATION WITH SUPINE
POSITION,EATING,DRINKING
H/O REFLUX
CAN RADIATE TO BACK
Treatment of acute coronary syndrome (ACS) should be directed by patient presentation.[1] The algorithm shown here shows the different treatment approaches (early invasive vs delayed invasive) that can be used in patients with unstable angina (UA) or non–ST-segment elevation myocardial infarction (NSTEMI; also known as non–Q-wave MI).
Bowen WE, Mckay RG. Optimal treatment of acute coronary syndromes—an evolving strategy. N Engl J Med. 2001;344:1939-1942. Editorial.
Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction. Available at: www.acc.org. Accessed March 19, 2002.
Acute medical management of patients with acute coronary syndrome should include supplemental oxygen and bed rest with continuous ECG monitoring; nitroglycerin (and morphine sulfate if nitroglycerin does not relieve symptoms); beta blockers (or nonhydropyridine calcium antagonists if beta blockers are contraindicated); and ACE inhibitors (in patients with continuing hypertension and left-ventricular dysfunction, chronic heart failure, or diabetes); and antiplatelet and anticoagulation therapy. Maintenance therapy in patients discharged following acute coronary syndrome should include antiplatelet therapy (aspirin or clopidogrel), beta blockers (in the absence of contraindications), calcium channel blockers, lipid-lowering agents (in patients with low-density lipoprotein [LDL] cholesterol of &gt;130 mg/dL), and ACE inhibitors (in patients with congestive heart failure, left-ventricular dysfunction, hypertension, or diabetes).
Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction. Available at: www.acc.org. Accessed March 19, 2002.